On air · 1 of 3 networks
Pharming Group
- pharming.com
- NL
- 811 employees
Pharming Group’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 48. Watch Pharming Group with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 42 | Checked 29 Oct 2026 | See all 48 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 7 Oct 2026 | Collect them with the API → |
Pharming Group has 42 live LinkedIn ads. We recorded no Google ads on 7 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 14 Jan 2026
- LINKEDIN · FOLLOWSince 4 May 2025
Get the latest jobs and industry news
- LINKEDIN · JOBSince 14 Jan 2025
- LINKEDIN · IMAGERecorded 28 Sept 2026
Five Posters. New Data. Join Pharming Group at ACAAI to learn all about new updates for HAE. Pharming will unveil five posters presenting compelling new data that underscores the clinical reliability, cost-effectiveness, and comparative strength of on-demand treatments for Hereditary Angioedema (HAE) management. Join us at the Pharming booth (#1209) to dive into the evidence and engage with the leaders in HAE research, innovation, and patient care. For more information on all Pharming presentations, please visit: https://lnkd.in/e7gmq3kb (COR-GLO-2025-0009)
- LINKEDIN · IMAGERecorded 28 Sept 2026
New evidence. Real impact. New updates for APDS. We will present seven scientific posters, including data from our Phase III pediatric trial, as well as real-world effectiveness and caregiver experience data on Activated PI3K Delta Syndrome (APDS), in an effort to inform and empower clinical decision-making in the diagnosis and treatment of this rare disease. Swing by our booth (#1209) to speak with the team and discover how Pharming Group is contributing to the evolving understanding of this rare, underdiagnosed condition. For more information on all Pharming presentations, please visit: https://lnkd.in/e7gmq3kb (COR-GLO-2025-0008)
- LINKEDIN · IMAGERecorded 28 Sept 2026
Heading to ACAAI 2025? Don't miss Pharming Group's new insights and important findings in APDS. We'll be presenting seven scientific posters on Activated PI3K Delta Syndrome (APDS), including data from our Phase III pediatric trial, real-world effectiveness and caregiver experience with APDS. Visit booth #1209 to learn more about Pharming’s contributions to advancing the understanding of this rare, underdiagnosed condition. For more information on all Pharming presentations, please visit: http://bit.ly/4qvMBA6 (COR-GLO-2025-0008)
6 of 48 adsSign up to see every Pharming Group ad, filter by format and date, and get alerts on new ones.
See all 48 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.